The Study Of Drug Price Supervision And Management Problems In Our Country

Drugs is a special commodity of the nature of public goods and social welfare, and related to people’s lives and health and safety.The pharmaceutical price regulation in the environment of health care reform is to improve the social basic medical coverage and build important part of the social medical insurance system Unreasonable drug prices result in medical costs rose sharply and expensive medical problems by community-wide focus of attention. The period from1996to2008, the government has more than30times down drug prices and also take other measures, such as drug bidding and purchasing, drug sales policy of zero difference of basic medical institutions, but the price of drugs has not been well controlled.Our per capita drug costs are continuing to improve.drug price regulation is also flawed. Therefore, to explore effective drug price regulatory measures is of great significance.The article focuses on the formation of drug prices and regulatory development, and then use linear regression to analyze the effect of the implementation of drug policy in recent years, found that the impact of policies on drug costs almost very small. Leading to high drug prices, the most important factors is the increase in production costs and public medical institutions monopoly position to influence the drug prices. First, the inputs of production enterprises increased, costs have increased, leading to rising drug prices. Secondly, although the pharmaceutical retail business rapid development in recent years, but the people of the purchase of medicines is still a single.channel.Hospital channel accounts for about80%of total sales. Third, the pharmaceutical information asymmetry that patients capacity is weak of choose drugs.Medical institutions in the formation of both pharmaceutical purchased by the monopoly, and monopoly on drug sales. Therefore, the pharmaceutical pricing policy is difficult to control pharmaceutical prices. This paper describes the historical evolution of the formation and regulation of drug prices and shortcomings, and conducted in-depth discussions on China’s drug prices regulation,Specific in terms of drug prices, drug costs, drug regulatory system analysis of drug price formation, artificially high drug prices, drug price control system status and problems. Comparative study of drug prices regulatory system, the pattern and measures in OECD countries, Raised countermeasures and thinking of building a regulatory system of drug prices in the new period.conducive to drug prices regulation and reduce the government and patients burden, also can promote the sustainable development of the pharmaceutical...